vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and Trade Desk (The) (TTD). Click either name above to swap in a different company.
Trade Desk (The) is the larger business by last-quarter revenue ($846.8M vs $493.8M, roughly 1.7× Pediatrix Medical Group, Inc.). Trade Desk (The) runs the higher net margin — 22.1% vs 6.8%, a 15.3% gap on every dollar of revenue. On growth, Trade Desk (The) posted the faster year-over-year revenue change (14.3% vs -1.7%). Over the past eight quarters, Trade Desk (The)'s revenue compounded faster (31.3% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
The Trade Desk, Inc. is an American multinational technology company that specializes in real-time programmatic marketing automation technologies, products, and services, designed to personalize digital content delivery to users.
MD vs TTD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $846.8M |
| Net Profit | $33.7M | $186.9M |
| Gross Margin | — | 80.7% |
| Operating Margin | 9.9% | 30.3% |
| Net Margin | 6.8% | 22.1% |
| Revenue YoY | -1.7% | 14.3% |
| Net Profit YoY | 10.5% | 2.6% |
| EPS (diluted) | $0.40 | $0.39 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $846.8M | ||
| Q3 25 | $492.9M | $739.4M | ||
| Q2 25 | $468.8M | $694.0M | ||
| Q1 25 | $458.4M | $616.0M | ||
| Q4 24 | $502.4M | $741.0M | ||
| Q3 24 | $511.2M | $628.0M | ||
| Q2 24 | $504.3M | $584.5M | ||
| Q1 24 | $495.1M | $491.3M |
| Q4 25 | $33.7M | $186.9M | ||
| Q3 25 | $71.7M | $115.5M | ||
| Q2 25 | $39.3M | $90.1M | ||
| Q1 25 | $20.7M | $50.7M | ||
| Q4 24 | $30.5M | $182.2M | ||
| Q3 24 | $19.4M | $94.2M | ||
| Q2 24 | $-153.0M | $85.0M | ||
| Q1 24 | $4.0M | $31.7M |
| Q4 25 | — | 80.7% | ||
| Q3 25 | — | 78.1% | ||
| Q2 25 | — | 78.2% | ||
| Q1 25 | — | 76.8% | ||
| Q4 24 | — | 81.7% | ||
| Q3 24 | — | 80.5% | ||
| Q2 24 | — | 81.1% | ||
| Q1 24 | — | 78.9% |
| Q4 25 | 9.9% | 30.3% | ||
| Q3 25 | 13.8% | 21.8% | ||
| Q2 25 | 12.8% | 16.8% | ||
| Q1 25 | 7.0% | 8.8% | ||
| Q4 24 | 7.8% | 26.4% | ||
| Q3 24 | 6.6% | 17.3% | ||
| Q2 24 | -31.3% | 16.2% | ||
| Q1 24 | 3.2% | 5.8% |
| Q4 25 | 6.8% | 22.1% | ||
| Q3 25 | 14.5% | 15.6% | ||
| Q2 25 | 8.4% | 13.0% | ||
| Q1 25 | 4.5% | 8.2% | ||
| Q4 24 | 6.1% | 24.6% | ||
| Q3 24 | 3.8% | 15.0% | ||
| Q2 24 | -30.3% | 14.5% | ||
| Q1 24 | 0.8% | 6.4% |
| Q4 25 | $0.40 | $0.39 | ||
| Q3 25 | $0.84 | $0.23 | ||
| Q2 25 | $0.46 | $0.18 | ||
| Q1 25 | $0.24 | $0.10 | ||
| Q4 24 | $0.37 | $0.36 | ||
| Q3 24 | $0.23 | $0.19 | ||
| Q2 24 | $-1.84 | $0.17 | ||
| Q1 24 | $0.05 | $0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $1.3B |
| Total DebtLower is stronger | $570.5M | — |
| Stockholders' EquityBook value | $865.9M | $2.5B |
| Total Assets | $2.2B | $6.2B |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $1.3B | ||
| Q3 25 | $340.1M | $1.4B | ||
| Q2 25 | $224.7M | $1.7B | ||
| Q1 25 | $99.0M | $1.7B | ||
| Q4 24 | $229.9M | $1.9B | ||
| Q3 24 | $103.8M | $1.7B | ||
| Q2 24 | $19.4M | $1.5B | ||
| Q1 24 | $8.0M | $1.4B |
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $865.9M | $2.5B | ||
| Q3 25 | $890.7M | $2.6B | ||
| Q2 25 | $833.8M | $2.7B | ||
| Q1 25 | $789.2M | $2.7B | ||
| Q4 24 | $764.9M | $2.9B | ||
| Q3 24 | $732.5M | $2.6B | ||
| Q2 24 | $706.5M | $2.4B | ||
| Q1 24 | $856.2M | $2.2B |
| Q4 25 | $2.2B | $6.2B | ||
| Q3 25 | $2.2B | $5.9B | ||
| Q2 25 | $2.1B | $6.0B | ||
| Q1 25 | $2.0B | $5.7B | ||
| Q4 24 | $2.2B | $6.1B | ||
| Q3 24 | $2.1B | $5.5B | ||
| Q2 24 | $2.0B | $5.2B | ||
| Q1 24 | $2.2B | $4.7B |
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $311.6M |
| Free Cash FlowOCF − Capex | — | $285.3M |
| FCF MarginFCF / Revenue | — | 33.7% |
| Capex IntensityCapex / Revenue | — | 3.1% |
| Cash ConversionOCF / Net Profit | 3.39× | 1.67× |
| TTM Free Cash FlowTrailing 4 quarters | — | $795.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $311.6M | ||
| Q3 25 | $137.3M | $224.7M | ||
| Q2 25 | $137.2M | $165.0M | ||
| Q1 25 | $-117.5M | $291.4M | ||
| Q4 24 | $133.0M | $199.4M | ||
| Q3 24 | $91.8M | $273.3M | ||
| Q2 24 | $107.0M | $81.3M | ||
| Q1 24 | $-125.2M | $185.5M |
| Q4 25 | — | $285.3M | ||
| Q3 25 | — | $158.3M | ||
| Q2 25 | — | $119.8M | ||
| Q1 25 | — | $232.3M | ||
| Q4 24 | — | $179.2M | ||
| Q3 24 | — | $224.6M | ||
| Q2 24 | — | $59.1M | ||
| Q1 24 | — | $178.2M |
| Q4 25 | — | 33.7% | ||
| Q3 25 | — | 21.4% | ||
| Q2 25 | — | 17.3% | ||
| Q1 25 | — | 37.7% | ||
| Q4 24 | — | 24.2% | ||
| Q3 24 | — | 35.8% | ||
| Q2 24 | — | 10.1% | ||
| Q1 24 | — | 36.3% |
| Q4 25 | — | 3.1% | ||
| Q3 25 | — | 9.0% | ||
| Q2 25 | — | 6.5% | ||
| Q1 25 | — | 9.6% | ||
| Q4 24 | — | 2.7% | ||
| Q3 24 | — | 7.8% | ||
| Q2 24 | — | 3.8% | ||
| Q1 24 | — | 1.5% |
| Q4 25 | 3.39× | 1.67× | ||
| Q3 25 | 1.91× | 1.94× | ||
| Q2 25 | 3.49× | 1.83× | ||
| Q1 25 | -5.66× | 5.75× | ||
| Q4 24 | 4.36× | 1.09× | ||
| Q3 24 | 4.72× | 2.90× | ||
| Q2 24 | — | 0.96× | ||
| Q1 24 | -31.03× | 5.86× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
TTD
| Other | $427.2M | 50% |
| Non Us | $419.6M | 50% |
